Pathway Therapeutics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 40

Employees

  • Latest Deal Type
  • M&A

Pathway Therapeutics General Information

Description

Developer of therapeutics against human diseases. The company offers PI3 kinase, an enzyme identified as active in cancer tumor development.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 409 Illinois Street
  • San Francisco, CA 94158
  • United States
+1 (415)
Primary Industry
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • 409 Illinois Street
  • San Francisco, CA 94158
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pathway Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 14-Aug-2013 Completed Generating Revenue
3. Debt - General 05-Mar-2013 Completed Generating Revenue
2. Early Stage VC (Series A1) 25-May-2011 $7.5M $16.3M Completed Generating Revenue
1. Early Stage VC (Series A) 10-Aug-2010 $8.75M $8.75M Completed Generating Revenue
To view Pathway Therapeutics’s complete valuation and funding history, request access »

Pathway Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1
Series A
To view Pathway Therapeutics’s complete cap table history, request access »

Pathway Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutics against human diseases. The company offers PI3 kinase, an enzyme identified as active in cance
Drug Discovery
San Francisco, CA
40 As of 2010

Norwood, MA
 

Santa Monica, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pathway Therapeutics Competitors (18)

One of Pathway Therapeutics’s 18 competitors is Corbus Pharmaceuticals Holdings, a Formerly VC-backed company based in Norwood, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Corbus Pharmaceuticals Holdings Formerly VC-backed Norwood, MA
Kite Pharma Formerly VC-backed Santa Monica, CA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Vertex Pharmaceuticals Formerly VC-backed Boston, MA
You’re viewing 5 of 18 competitors. Get the full list »

Pathway Therapeutics Patents

Pathway Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2012135160-A1 (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases Inactive 28-Mar-2011
WO-2012135175-A1 (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases Inactive 28-Mar-2011
WO-2012135166-A1 (fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases Inactive 28-Mar-2011
WO-2012044641-A1 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy Inactive 29-Sep-2010
EP-2532659-A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy Inactive 07-Jul-2009 C07D487/04
To view Pathway Therapeutics’s complete patent history, request access »

Pathway Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pathway Therapeutics Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aspire NZ Seed Fund Venture Capital Minority
Auckland UniServices Corporate Venture Capital Minority
Breast Cancer Research Trust Corporation Minority
GBS Venture Partners Venture Capital Minority
Talu Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Pathway Therapeutics FAQs

  • When was Pathway Therapeutics founded?

    Pathway Therapeutics was founded in 2008.

  • Where is Pathway Therapeutics headquartered?

    Pathway Therapeutics is headquartered in San Francisco, CA.

  • What is the size of Pathway Therapeutics?

    Pathway Therapeutics has 40 total employees.

  • What industry is Pathway Therapeutics in?

    Pathway Therapeutics’s primary industry is Drug Discovery.

  • Is Pathway Therapeutics a private or public company?

    Pathway Therapeutics is a Private company.

  • What is Pathway Therapeutics’s current revenue?

    The current revenue for Pathway Therapeutics is .

  • How much funding has Pathway Therapeutics raised over time?

    Pathway Therapeutics has raised $16.9M.

  • Who are Pathway Therapeutics’s investors?

    Aspire NZ Seed Fund, Auckland UniServices, Breast Cancer Research Trust, GBS Venture Partners, and Talu Ventures are 5 of 6 investors who have invested in Pathway Therapeutics.

  • Who are Pathway Therapeutics’s competitors?

    Corbus Pharmaceuticals Holdings, Kite Pharma, Adaptimmune Therapeutics, Inovio Pharmaceuticals, and Vertex Pharmaceuticals are some of the 18 competitors of Pathway Therapeutics.

  • When was Pathway Therapeutics acquired?

    Pathway Therapeutics was acquired on 14-Aug-2013.

  • Who acquired Pathway Therapeutics?

    Pathway Therapeutics was acquired by VetDC.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process